home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops
Search  -  prev / next
 
 

Virtual Seminar on FDA's Scrutiny of Social Media Promotion

 
  January 30, 2019  
     
 
Traininng.com LLC, Fremont
2019-03-12


Overview

 

FDA steadily expands the scope and restrictions for promotion of products under its jurisdiction. Whatever and where ever to want to talk about your product, just assume your talking to FDA.

Trolling for off-label information in social media, scrutiny of educational material under "safe harbor" and apparent conflicts of interest at a public event create a sink hole for firms even though it may seem innocent in your eyes.

Facebook, Twitter or chat rooms can be rampant with off-label information. You even may be surprised about what people are saying about your product. Does FDA hold you accountable?

 

Why should you Attend

 

  • Limitations on commercial free speech
  • Avenues of off-label information
  • Working in a "safe harbor" for off-label information distribution
  • Social media and your regulatory responsibilities
  • Correcting off-label information
  • Factoring in cognitive psychology

 

Areas Covered in the Session

 

  • Learn to navigate through FDA requirements
  • Understand that your right to free speech is limited
  • How to get around FDA prohibitions
  • Ways to manage your presence in social media
  • How to identify an off-label problem and corrective action
  • Under how FDA applies cognitive psychology principles

 

Who Will Benefit

 

  • Regulatory Directors
  • Marketing Directors
  • Quality Systems Auditors
  • Recall Managers
  • In-house Legal Counsel
  • Customer Support Staff
  • Sales Staff
 
 
Organized by: Traininng.com LLC
Invited Speakers:

Speaker Profile:

Casper (Cap) Uldriks through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value. 

 
Deadline for Abstracts: 2019-03-11
 
Registration: www.traininng.com/webinar/3-hour-virtual-seminar-on-fda's-scrutiny-of-social-media-promotion--200598live?hum-molgen-Mar-Seo-2019
E-mail: traininngdotcom@gmail.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.